Non-steroidal anti-inflammatory drugs (NSAID)
PreclinicalSmall molecule
RocheNon-steroidal anti-inflammatory drugs (NSAID) is one of 136 small molecule programs targeting Autoimmune Disease. It is currently in Preclinical.
4
Indications
6
Total Trials
4
Active Trials
135
Competitors
Pipeline
Status by Indication[3][1]
Indication
Competition
Competitive Landscape
102 competitors in Migraine
#DrugCompanyPhaseTrials
1Zonegran
AAzurity Pharmaceuticals
Phase 3
Avicel
SSanthera Pharmaceuticals
Phase 3
Effient
CCosette Pharmaceuticals, Inc.
Phase 3
Magnesium
SSpherium Biomed
Phase 3
Flunarizine
AAspartes Pharmaceuticals, Inc.
Phase 3
Tizanidine Hydrochloride
EElan Pharmaceuticals
Phase 3
Bayer Aspirin
BayerPreclinical
Cervidil
PfizerPreclinical
Cymbalta
Jazz PharmaceuticalsPreclinical
Adempas
BayerPreclinical
Ranked by pipeline maturity and clinical activity. Current drug highlighted in teal.
Timeline
Expected Milestones
Clinical
Trials by Indication[1]
Cesarean Section1 trial
Postoperative in Cesarean Section, the Women Suffering from Pain Due to Wound "incisional Pain", High Level Laser One of Most Effective Methods That Promoting Healing and Decrease Pain so It Will Effective If Use in Decreasing Pain of Cesarian Section
Enrolling by invitation·—·N/A·NCT06793293·40 enrolled
Neck pain1 trial
Chiropractic Care, Medication, and Self-Care for Neck Pain
Completed·NNational Center for Complementary and Integrative Health (NCCIH)·Phase 2·NCT00029770·270 enrolled
Systemic Juvenile Idiopathic Arthritis1 trial
Migraine1 trial
Effect of Manual Therapy on Migraine in Postmenopausal Women
Not yet recruiting·—·N/A·NCT07127107·40 enrolled
1 more indication
Autoimmune Disease1 trial
Effect of Transcutaneous Electrical Acupoint Stimulation on Dysmenorrhea Among Autoimmune Disease Women
Not yet recruiting·—·N/A·NCT06976151·52 enrolled
Sources
References
- [1]
- [2]
- [3]
- [4]